Genting Bhd Vs. NovoCure Industry Stock Comparison

Buy

62

GEBHY
Genting Bhd

Last Price:

$4.51

Seasonality Move:

5.01%

Sell

49

NVCR
NovoCure

Last Price:

$30.18

Seasonality Move:

-3.69%

Buy

62

Genting Bhd (GEBHY) is a Buy

Is Genting Bhd a Buy, Sell or Hold?

The current Genting Bhd [GEBHY] share price is $4.51. The Score for GEBHY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
GEBHY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

49

NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GEBHY Stock Price Chart

What is Genting Bhd's stock price today?

The Genting Bhd share price today is $4.51

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GEBHY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $30.19

The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

GEBHY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	61.4	Buy
Chaikin Money Flow:	14359	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.8 - 4.18)	Buy
Bollinger Bands (100):	(4.11 - 5.19)	Sell

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.94	Buy
Relative Strength Index (14 RSI):	58.79	Buy
Chaikin Money Flow:	-60501	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(26.36 - 32.64)	Buy
Bollinger Bands (100):	(14.38 - 25.86)	Buy

GEBHY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.19	Buy
20-day SMA:	4	Buy
50-day SMA:	4.19	Buy
200-day SMA:	4.81	Sell
8-day EMA:	4.22	Buy
20-day EMA:	4.1	Buy
50-day EMA:	4.23	Buy
200-day EMA:	4.67	Sell

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30.52	Sell
20-day SMA:	30.41	Sell
50-day SMA:	23.25	Buy
200-day SMA:	18.89	Buy
8-day EMA:	30.36	Sell
20-day EMA:	29.22	Buy
50-day EMA:	25.18	Buy
200-day EMA:	21.21	Buy

Genting Bhd Earnings Growth & GEBHY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

Genting Bhd Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):